Antibodies would be the top class of therapeutics, thanks largely to their capacity to interact with distinctive ligand conformations in order to elicit distinct Organic responses. Nonetheless, discovery of new molecules binding specific epitopes is time intensive and tough, especially for cases demanding a certain antibody-ligand orientation to in